Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
Federal Trade Commission
McKesson
Johnson and Johnson
Novartis
Farmers Insurance
Healthtrust
Argus Health
Queensland Health
US Department of Justice

Generated: October 18, 2017

DrugPatentWatch Database Preview

IMIQUIMOD Drug Profile

« Back to Dashboard

What is the patent landscape for Imiquimod, and what generic Imiquimod alternatives are available?

Imiquimod is a drug marketed by Strides Pharma, Apotex Inc, Perrigo Israel, Tolmar, Fougera Pharms, Taro, G And W Labs Inc, and Glenmark Generics. and is included in eight NDAs.

The generic ingredient in IMIQUIMOD is imiquimod. There are fourteen drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the imiquimod profile page.

Summary for Tradename: IMIQUIMOD

US Patents:0
Applicants:8
NDAs:8
Suppliers / Packagers: see list8
Bulk Api Vendors: see list86
Clinical Trials: see list124
Patent Applications: see list5,795
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:IMIQUIMOD at DailyMed

Pharmacology for Tradename: IMIQUIMOD

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Strides Pharma
IMIQUIMOD
imiquimod
CREAM;TOPICAL202002-001Jun 24, 2014ABRXNoNo► Subscribe► Subscribe► Subscribe
G And W Labs Inc
IMIQUIMOD
imiquimod
CREAM;TOPICAL200481-001Apr 18, 2011ABRXNoNo► Subscribe► Subscribe► Subscribe
Tolmar
IMIQUIMOD
imiquimod
CREAM;TOPICAL091044-001Feb 28, 2011ABRXNoNo► Subscribe► Subscribe► Subscribe
Glenmark Generics
IMIQUIMOD
imiquimod
CREAM;TOPICAL201994-001Mar 6, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe
Apotex Inc
IMIQUIMOD
imiquimod
CREAM;TOPICAL091308-001Apr 6, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe
Perrigo Israel
IMIQUIMOD
imiquimod
CREAM;TOPICAL078837-001Sep 7, 2010ABRXNoNo► Subscribe► Subscribe► Subscribe
Taro
IMIQUIMOD
imiquimod
CREAM;TOPICAL200173-001Apr 15, 2011ABRXNoNo► Subscribe► Subscribe► Subscribe
Fougera Pharms
IMIQUIMOD
imiquimod
CREAM;TOPICAL078548-001Feb 25, 2010ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Deloitte
UBS
Daiichi Sankyo
Citi
Cipla
Julphar
Federal Trade Commission
Covington
Moodys
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot